Perceptive Advisors LLC Seres Therapeutics, Inc. Transaction History

Perceptive Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$2.29 - $4.16 $5.73 Million - $10.4 Million	-2,500,000 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$2.28 - $7.35 $5.7 Million - $18.4 Million	2,500,000 New	2,500,000 $8.05 Million
Q4 2017 Feb 14, 2018	SELL	$9.15 - $12.64 $1.24 Million - $1.71 Million	-135,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$12.81 - $16.85 $1.73 Million - $2.27 Million	135,000	135,000 $2.17 Million

100

62.7M

36.9K

476K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $89.3M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Perceptive Advisors LLC with notifications on news.